About
Allosterix Pharmaceuticals has developed a patent-pending technology for locating allosteric sites andpeptidic drug design. The companys approach to drug design involves creating inhibitors based on the principles of allostery. The advantage of this approach is greater specificity, as selectivity is inherent in each peptidic inhibitor. Allosteric sites are located distal to the active site, in nonconserved regions of the enzyme. By designing drugs for these regions, researchers can produce inhibitors with unprecedented selectivity profiles. This is a departure from previous drug design strategies aimed at inhibiting enzymatic functions. These allosteric inhibitors show little to no reactivity with other enzymes, even very closely related enzymes. This translates into a low incidence of unwanted side effects or toxicity, giving an allosteric inhibitor a significantly higher chance of success at the clinical stage. Allosterix Pharmaceuticals LLC is currently part of Silicon Slopes, a nonprofit organization and start-up greenhouse located in Lehi, Utah, USA.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is the primary focus of Allosterix Pharmaceuticals' technology?
- Allosterix Pharmaceuticals focuses on developing a patent-pending technology for locating allosteric sites and designing peptidic drugs, aiming for highly selective peptide-based inhibitors.
- When was Allosterix Pharmaceuticals founded?
- Allosterix Pharmaceuticals was founded in July 2007.
- What is the current operational status of Allosterix Pharmaceuticals?
- Allosterix Pharmaceuticals is currently inactive, as of December 2012.
- Where is Allosterix Pharmaceuticals primarily headquartered?
- Allosterix Pharmaceuticals' primary headquarters is located in Shilat, Center District, Israel.
- Does Allosterix Pharmaceuticals have an office in the United States?
- Yes, Allosterix Pharmaceuticals has an office in Lehi, Utah, USA.
- What is Allosterix Pharmaceuticals' current funding stage?
- Allosterix Pharmaceuticals is currently in the Pre-Funding stage.
- How many employees does Allosterix Pharmaceuticals have?
- Allosterix Pharmaceuticals has between 1-10 employees.
- Who are the founders of Allosterix Pharmaceuticals?
- The founders of Allosterix Pharmaceuticals are Dr. Ariel Solomon and Omer Vunsch.
- What is the advantage of Allosterix Pharmaceuticals' allosteric inhibitor approach?
- The advantage of Allosterix Pharmaceuticals' allosteric inhibitor approach is greater specificity and selectivity, leading to a low incidence of unwanted side effects or toxicity.